Question | Discussion | References | CME Credit

Case 4: References

  1. Lambert JS, Seidlin M, Reichman RC, et al. 2'-3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A Phase I trial. N Engl J Med. 1990;322:1333-40.
    [The following link will open in a new window. PubMed Abstract]
  2. Cooley TP, Kunches LM, Saunders CA, et al. Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial. N Engl J Med. 1990;322:1340-45.
    [The following link will open in a new window. PubMed Abstract]
  3. Schindzielorz A, Pike I, Daniels M, Pacelli L, Smaldone L. Rates and risk factors for adverse events associated with didanosine in the expanded access program. Clin Infect Dis. 1994;19:1076-83.
    [The following link will open in a new window. PubMed Abstract]
  4. Grasela TH, Walawander CA, Betangady M, et al. Analysis of potential risk factors associated with the development of pancreatitis is phase 1 patients with AIDS or AIDS-related complex receiving didanosine. J Infect Dis. 1994;169:1250-5.
    [The following link will open in a new window. PubMed Abstract]
  5. Maxson CJ, Greenfield SM, Turner JL. Acute pancreatitis as a common complication of 2',3'-dideoxyinosine therapy in the acquired immunodeficiency syndrome. Am J Gastroenterol. 1992;87:708-13.
    [The following link will open in a new window. PubMed Abstract]
  6. Lambert JS, Seidlin M, Valentine FT, Reichman RC, Dolin R. Didanosine: long-term follow-up of patients in a phase 1 study. Clin Infect Dis. 1993;16 Suppl 1:S40-5.
    [The following link will open in a new window. PubMed Abstract]
  7. Moore RD, Keruly JC, Chaisson RE. Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs. AIDS. 2001;15:617-20.
    [The following link will open in a new window. PubMed Abstract]
  8. Blanchard JN, Wohlfeiler M, Canas A, King K, Lonergan JT. Pancreatitis with didanosine and tenofovir disoproxil fumarate. Clin Infect Dis. 2003;37:e57-62.
    [The following link will open in a new window. PubMed Abstract]
  9. Young B, Weidle PJ, Baker RK, et al. Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons. AIDS Patient Care STDS. 2006;20:238-44.
    [The following link will open in a new window. PubMed Abstract]
  10. Lafeuillade A, Hittinger G, Chadapaud S. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection. Lancet. 2001;357:280-1.
    [The following link will open in a new window. PubMed Abstract]
  11. Salmon-Ceron D, Chauvelot-Moachon L, Abad S, Silbermann B, Sogni P. Mitochondrial toxic effects and ribavirin. Lancet. 2001;357:1803-4.
    [The following link will open in a new window. PubMed Abstract]
  12. Bruno R, Sacchi P, Filice G. Didanosine-ribavirin combination: synergistic combination in vitro, but high potential risk of toxicity in vivo. AIDS. 2003;17:2665-7.
    [The following link will open in a new window. PubMed Abstract]
  13. Bani-Sadr F, Carrat F, Pol S, et al. Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy. J Acquir Immune Defic Syndr. 2005;40:47-52.
    [The following link will open in a new window. PubMed Abstract]
  14. Brinkman K, ter Hofstede HJ, Burger DM, Smeitink JAM, Koopmans PP. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS. 1998;12:1735-44.
    [The following link will open in a new window. PubMed Abstract]
  15. Videx EC Prescribing Information.
    [The following link will open in a new window. PDF Document - Accessed September 15, 2006]
  16. Dassopoulos T, Ehrenpreis ED. Acute pancreatitis in human immunodeficiency virus-infected patients: a review. Am J Med. 1999;107:78-84.
    [The following link will open in a new window. PubMed Abstract]
  17. Banks PA. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 1997;92:377-86.
    [The following link will open in a new window. PubMed Abstract]
  18. Bouvet E, Casalino E, Prevost MH, Vachon F. Fatal case of 2',3'-dideoxyinosine-associated pancreatitis. Lancet. 1990;336:1515.
    [The following link will open in a new window. PubMed Abstract]

[Back to Case 4 Question | Back to Discussion]

CME Credit | Back to Top